Immunological aspects of cancer chemotherapy

被引：1338
作者：
Zitvogel, Laurence [1 ,2 ,3 ]
Apetoh, Lionel [1 ,3 ]
Ghiringhelli, Francois [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ]
机构：
[1] Inst Gustave Roussy, INSERM, U805, F-94805 Villejuif, France
[2] Inst Gustave Roussy, CIC BT507, F-94805 Villejuif, France
[3] Univ Paris 11, Fac Med Paris Sud, F-94276 Le Kremlin Bicetre, France
[4] Ctr Georges Francois Leclerc, F-21000 Dijon, France
[5] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France
来源：
NATURE REVIEWS IMMUNOLOGY | 2008年 / 8卷 / 01期
关键词：
D O I：
10.1038/nri2216
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Accumulating evidence indicates that the innate and adaptive immune systems make a crucial contribution to the antitumour effects of conventional chemotherapy-based and radiotherapy-based cancer treatments. Moreover, the molecular and cellular bases of the immunogenicity of cell death that is induced by cytotoxic agents are being progressively unravelled, challenging the guidelines that currently govern the development of anticancer drugs. Here, we review the immunological aspects of conventional cancer treatments and propose that future successes in the fight against cancer will rely on the development and clinical application of combined chemo- and immunotherapies.
引用
收藏
页码：59 / 73
页数：15
相关论文
共 124 条
[41]  
Gaugler MH, 1997, INT J RADIAT BIOL, V72, P201, DOI 10.1080/095530097143428
[42]   Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments [J].
Ge, Q ;
Hu, H ;
Eisen, HN ;
Chen, JZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :2989-2994
[43]   CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative [J].
Ghiringhelli, F ;
Larmonier, N ;
Schmitt, E ;
Parcellier, A ;
Cathelin, D ;
Garrido, C ;
Chauffert, B ;
Solary, E ;
Bonnotte, B ;
Martin, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :336-344
[44]   CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner [J].
Ghiringhelli, F ;
Ménard, C ;
Terme, M ;
Flament, C ;
Taieb, J ;
Chaput, N ;
Puig, PE ;
Novault, S ;
Escudier, B ;
Vivier, E ;
Lecesne, A ;
Robert, C ;
Blay, JY ;
Bernard, J ;
Caillat-Zucman, S ;
Freitas, A ;
Tursz, T ;
Wagner-Ballon, O ;
Capron, C ;
Vainchencker, W ;
Martin, F ;
Zitvogel, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1075-1085
[45]   Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients [J].
Ghiringhelli, Francois ;
Menard, Cedric ;
Puig, Pierre Emmanuel ;
Ladoire, Sylvain ;
Roux, Stephan ;
Martin, Francois ;
Solary, Eric ;
Le Cesne, Axel ;
Zitvogel, Laurence ;
Chauffert, Bruno .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (05) :641-648
[46]   REGULATION OF SPECIFIC CELL-MEDIATED CYTOTOXIC RESPONSE AGAINST SV40-INDUCED TUMOR ASSOCIATED ANTIGENS BY DEPLETION OF SUPPRESSOR T-CELLS WITH CYCLOPHOSPHAMIDE IN MICE [J].
GLASER, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (03) :774-779
[47]   Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer [J].
Gomez, GG ;
Hutchison, RB ;
Kruse, CA .
CANCER TREATMENT REVIEWS, 2001, 27 (06) :375-402
[48]   Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy [J].
Gribben, JG ;
Ryan, DP ;
Boyajian, R ;
Urban, RG ;
Hedley, ML ;
Beach, K ;
Nealon, P ;
Matulonis, U ;
Campos, S ;
Gilligan, TD ;
Richardson, PG ;
Marshall, B ;
Neuberg, D ;
Nadler, LM .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4430-4436
[49]   One hundred consecutive isolated limb perfusions with TNF-α and melphalan in melanoma patients with multiple in-transit metastases [J].
Grünhagen, DJ ;
Brunstein, F ;
Graveland, WJ ;
van Geel, AN ;
de Wilt, JHW ;
Eggermont, AMM .
ANNALS OF SURGERY, 2004, 240 (06) :939-948
[50]  
HAREYAMA M, 1988, Nippon Acta Radiologica, V48, P1572
12345678910